Lava Medtech Acquisition Valuation

LVACUDelisted Stock  USD 10.40  0.00  0.00%   
At this time, the firm appears to be overvalued. Lava Medtech Acquisition secures a last-minute Real Value of $8.84 per share. The latest price of the firm is $10.4. Our model forecasts the value of Lava Medtech Acquisition from analyzing the firm fundamentals such as Number Of Shares Shorted of 105, return on asset of -0.0081, and Net Income of 4.5 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
10.40
Please note that Lava Medtech's price fluctuation is very steady at this time. Calculation of the real value of Lava Medtech Acquisition is based on 3 months time horizon. Increasing Lava Medtech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Lava Medtech's intrinsic value may or may not be the same as its current market price of 10.40, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  10.4 Real  8.84 Hype  10.4 Naive  10.4
The intrinsic value of Lava Medtech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Lava Medtech's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
8.84
Real Value
11.44
Upside
Estimating the potential upside or downside of Lava Medtech Acquisition helps investors to forecast how Lava stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lava Medtech more accurately as focusing exclusively on Lava Medtech's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
10.4010.4010.40
Details
Hype
Prediction
LowEstimatedHigh
10.4010.4010.40
Details
Naive
Forecast
LowNext ValueHigh
10.4010.4010.40
Details

Lava Medtech Total Value Analysis

Lava Medtech Acquisition is now forecasted to have takeover price of 0 with market capitalization of 0, debt of 92.81 K, and cash on hands of 1.15 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Lava Medtech fundamentals before making investing decisions based on enterprise value of the company

Lava Medtech Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of Lava implies not a very effective usage of assets in January.

Lava Medtech Profitability Analysis

Net Income was 4.5 M with profit before overhead, payroll, taxes, and interest of 0.

About Lava Medtech Valuation

The delisted stock valuation mechanism determines Lava Medtech's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Lava Medtech Acquisition based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lava Medtech. We calculate exposure to Lava Medtech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Lava Medtech's related companies.
LAVA Medtech Acquisition Corp. does not have significant operations. LAVA Medtech Acquisition Corp. is a subsidiary of LAVA Medtech Sponsor LP. Lava Medtech is traded on NASDAQ Exchange in the United States.

Lava Medtech Growth Indicators

Investing in growth stocks can be very risky. If the company such as Lava Medtech does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding11.5 M
Quarterly Earnings Growth Y O Y-0.951
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Consideration for investing in Lava Stock

If you are still planning to invest in Lava Medtech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lava Medtech's history and understand the potential risks before investing.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Valuation
Check real value of public entities based on technical and fundamental data
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios